Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Verici Dx (AIM: VRCI): New York Certification Completes Nationwide US Access for Tutivia — Does Commercial Momentum Justify the Dilution?

On 24 June 2026, Verici Dx plc (AIM: VRCI) announced via RNS that it had received Clinical Laboratory Evaluation Program (CLEP) certification from the New York State Department of Health for its Tutivia kidney-transplant rejection test. The company said the approval completes its authorisation …

Divya Sood | 28 July 2026

Feedback plc (LSE: FDBK): National Bleepa Rollout Decision Slips to 2026/27 — Shares Near Lows as Cash Clock Ticks

Investors in Feedback plc (LSE/AIM: FDBK) began 2026 hoping for confirmation that its Bleepa clinical-communications platform had won a place in a nationwide NHS rollout. What arrived instead, in a Regulatory News Service announcement on 20 April 2026, was a delay. The central NHS …

Divya Sood | 28 July 2026

Surgical Innovations (LSE: SUN): Elemental Healthcare Wins Place on NHS MIS3 Framework — Modest Turnaround Meets a Micro-Cap Reality Check

That is genuinely material — but the way it matters is worth being precise about. This is not a new contract with a stated value. It is renewed pre-qualification: a licence to compete for NHS business, following Elemental's participation in the earlier MIS1 and …

Divya Sood | 28 July 2026

TheraCryf (LSE: TCF): Addiction Drug Passes Preclinical Safety Tests — But Rejected Takeover Bid and a 2026 Cash Horizon Frame the Real Story

TheraCryf plc (LSE: TCF) is one of the London market's smallest clinical-stage biotechs, valued at roughly £4.2m and trading at about 0.195p on 28 July 2026, near the bottom of a 52-week range of 0.18p–0.265p (shareprices.com, 28 July 2026). Behind that penny-stock façade sits …

Divya Sood | 28 July 2026

Could LSE:OBD Be the UK Healthcare Stock Everyone Is Suddenly Watching After a 25% Rally?

Oxford BioDynamics Plc has emerged as one of the strongest-performing UK healthcare stocks on 28 July 2026 after its shares advanced around 25%, making it one of the day's biggest gainers on the London market.

Ankur Sharma | 28 July 2026

Why Did LSE:THAT Shares Fall More Than 7% Today? Latest Thalia Therapeutics PLC News Investors Need to Know

Thalia Therapeutics PLC emerged as one of the notable healthcare movers on the London Stock Exchange after its shares declined approximately7.14% on 28 July 2026.

Ankur Sharma | 28 July 2026

Why Did LSE:FDBK Shares Fall Nearly 6% Today? Latest Feedback plc News Investors Are Watching

Feedback plc became one of the notable healthcare movers after its shares declined approximately5.69% on 28 July 2026.

Ankur Sharma | 28 July 2026

Can Smith and Nephew plc Sustain Its Momentum?

Recent Share Price Change:Smith and Nephew plc shares (SN.) recently increased by +0.22%, moving +2.50 to GBX 1,164.50.

Ishan Mudgal | 28 July 2026

Can Cost Savings and Higher Private Revenue Lift Spire's Margins?

Spire Healthcare Group PLC shares gained1.30% today (28 July 2026), with the stock remaining supported by a combination of improving private-patient demand, expectations for FY2026 growth and recent corporate activity.

Divya Sood | 28 July 2026

Is CVS Group Still Expanding Through Acquisitions?

CVS Group PLC (LSE:CVSG) is a major veterinary-services provider operating across theUK and Australia.

Divya Sood | 28 July 2026
Support

Hi! How can we help you today?

Loading…